Skip to content
Homepage
Clinic directory

Clinics in Vancouver, Washington

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Vancouver, WA

Ketamine Therapy clinics in Vancouver

Vancouver has multiple clinics offering ketamine therapy, a fast growing segment for treatment resistant depression, PTSD, chronic pain, and anxiety. Washington permits ketamine infusions by licensed MD/DO and qualified NPs with prescriptive authority under WAC rules. Most Vancouver clinics deliver IV ketamine infusions in a monitored clinical setting, typically across a 6 session induction protocol, followed by maintenance infusions. Spravato (esketamine), the FDA approved nasal spray for treatment resistant depression, is available in Vancouver only at REMS certified clinics and is often covered by insurance when medical necessity is documented. Compounded ketamine lozenges and troches are also prescribed in Vancouver, sometimes through telehealth platforms like Mindbloom, Joyous, and Innerwell, subject to Ryan Haight Act and DEA special registration considerations. Local pricing in Vancouver sits in the affordable range: single IV infusions run 400 to 700 dollars, a full 6 session protocol lands at 2,400 to 4,200, and Spravato copays depend on insurance coverage. A reputable Vancouver ketamine clinic will pair pharmacology with integration support, monitor vitals during infusion, and have a clear crisis and follow up plan.

2 Clinics

MD on staff

Active Path

Vancouver, WA

Active Path, a ketamine and psychedelic-assisted therapy clinic in Vancouver, specializes in esketamine and ketamine infusion protocols for treatment-resistant depression, anxiety, and related mood c…

  • Transcranial Magnetic Stimulation (TMS)
  • Ketamine Therapy
 MD on staff

CURE Spine & Sports Medicine

Vancouver, WA

CURE Spine & Sports Medicine in Vancouver, Washington, offers regenerative orthobiologics and cell-based therapies for chronic spinal and musculoskeletal conditions. The clinic specializes in platele…

  • PRP Therapy
  • IV Therapy
  • Ketamine Therapy
  • Arthritis Treatment
  • Stem Cell Therapy
15 30 50 results per page

Regulatory context

A note on Washington's ketamine therapy rules.

Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.

  • SB 5263 / Psilocybin Task Force (2023)
    Established a state psilocybin task force and authorized a pilot psilocybin services program for veterans and first responders, with UW School of Medicine oversight.
  • Local decriminalization
    Seattle (2021), Port Townsend, and Olympia have passed resolutions deprioritizing enforcement of entheogenic plants.
  • Washington Uniform Controlled Substances Act
    Mirrors federal scheduling.

Washington enforces federal scheduling outside the pilot program. The Washington Medical Commission oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Washington PMP requires controlled substance reporting. The UW-affiliated psilocybin pilot operates within federal research compliance.

Sources: dea.gov · doh.wa.gov · doh.wa.gov · app.leg.wa.gov

Ketamine Therapy in Vancouver, answered.

In Vancouver, a single IV ketamine infusion typically runs 400 to 700 dollars, with a full 6 session induction protocol at 2,400 to 4,200. Premium clinics on the higher end, more affordable providers on the lower end. Intramuscular ketamine often costs less, around 250 to 500 per session. Compounded ketamine lozenges via telehealth run 250 to 500 per month. Spravato (esketamine) is frequently covered by insurance for treatment resistant depression; out of pocket list price is roughly 600 to 900 per treatment session, with most patients paying a copay.

Ketamine is a Schedule III controlled substance and has been FDA approved as an anesthetic since 1970. Spravato (esketamine), a derivative nasal spray, is FDA approved for treatment resistant depression under a REMS program requiring in clinic administration and post dose monitoring. IV, intramuscular, and compounded oral ketamine for depression, PTSD, and chronic pain are used off label with Emerging to Strong evidence depending on indication. Off label prescribing is legal for DEA registered providers but must follow state and federal controlled substance rules.

Vancouver ketamine is delivered by MDs and DOs (typically psychiatrists, anesthesiologists, emergency medicine, or pain specialists) holding a DEA registration and Washington controlled substance authority. Nurse practitioners and physician assistants may prescribe or administer depending on Washington scope of practice and supervisory rules. Spravato requires a REMS certified clinic and certified prescriber. Verify the provider's DEA registration, board certification, and whether a monitoring clinician is present during infusions.

Yes, with caveats. Mindbloom, Joyous, Innerwell, and similar platforms prescribe compounded ketamine lozenges to Washington residents through telehealth, subject to the Ryan Haight Act and DEA special registration rules currently in effect. These programs pair at home dosing with virtual integration support and cost roughly 250 to 500 per month. In clinic IV and intramuscular ketamine remain the standard for treatment resistant depression and PTSD and cannot be delivered via telehealth. Spravato always requires in clinic REMS administration.

Verify DEA registration on the DEA Office of Diversion Control registrant lookup and Washington medical board license status. Confirm board certification in psychiatry, anesthesiology, emergency medicine, or pain medicine. Ask about the monitoring protocol during infusion (vitals, continuous clinician presence), integration therapy options, and the clinic's crisis and safety plan. Check whether the clinic is Spravato REMS certified if that is your treatment path. Be cautious of providers who skip screening, push large prepaid packages, or offer take home IV ketamine.

Treatment guide

Learn about Ketamine Therapy

What it is, how it works, and what to expect.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology